BackEasywell Biomedicals Overview

Easywell Biomedicals Receivables

Track Easywell Biomedicals's receivables ($32M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$32.19M
↓ 12.29% YoYΔ $-4.51M vs prior year quarter

Peer trimmed avg / median

Loading

Easywell Biomedicals Receivables History

Loading

Easywell Biomedicals vs. peers: Receivables Comparison

Loading

Easywell Biomedicals Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Easywell Biomedicals (1799.TWO) FAQ

As of the most recent data (June 2026), 1799.TWO shows a receivables of $32M. That compares with $37M in the prior-year period — down 12.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 1799.TWO's receivables is now $32M (was $37M) — a 12.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Easywell Biomedicals is outperforming or lagging.

Tracking 1799.TWO's receivables over time shows whether Easywell Biomedicals is scaling, shrinking, or reshaping that part of the business. The current reading is $32M That compares with $37M in the prior-year period — down 12.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Easywell Biomedicals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $32M) with ownership activity and broader fundamentals.